Research into the prevention and cure of male cancers

Everyman is an appeal raising funds for research into male cancers at The Institute of Cancer Research (ICR), set up in 1997 to address an urgent lack of funding for prostate and testicular cancer research. Today, prostate cancer is the most common cancer in British men with 37,000 new cases diagnosed each year, whilst testicular cancer remains the most common cancer in younger men aged 15-44. The ICR is one of the world’s most influential cancer research institutes, with a mission to make the discoveries that defeat cancer.

Scientists at the ICR have made significant breakthroughs in the diagnosis and treatment of male cancers, but more needs to be done. Your pennies helped the Everyman appeal and ICR scientists make a real impact on cancer patients’ lives through innovative research, like developing a new blood test that predicts the aggressiveness of male cancers

Everyman logo
Supported from

March 2012 – May 2013

Previously supported by